Live news related to ADOCIA stock (FR0011184241): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Lyon-based biopharmaceutical company Adocia has announced the dates for its financial publications and general assembly for the fiscal year 2026.
Lyon-based biopharmaceutical company Adocia has announced the publication dates for its financial and operational indicators for the year 2026, accord…
Biopharmaceutical company Adocia announces the filing of a patent for its AdoXLong platform, aimed at extending the action of peptides to one month.
Adocia and its partner Tonghua Dongbao have announced positive results from a Phase 3 clinical trial of BioChaperone® Lispro, an ultra-rapid insulin, …
Adocia has released its financial results for the third quarter of 2025 and reported clinical progress on its ultra-rapid BioChaperone® Lispro insulin…
The Lyon-based company specializing in diabetes and obesity treatments experienced a particularly dynamic week, closing at €9.75 on Friday, October 10…
